Tag: oncohost

[OncoHost in PR Newswire] OncoHost announces interim results from PROPHETIC trial, multicenter assessment of NSCLC patient response to immunotherapy

OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These interim results confirm that through proteomic analysis of just one blood test before treatment, OncoHost’s AI platform, PROphet®, can predict response to cancer treatment for non-small cell lung cancer (NSCLC) patients with remarkably high accuracy at three months, six months and one year. Read...

Read More

[OncoHost in The Jerusalem Post] Israeli research institute makes great contributions to cancer research

Graduates and professors of Israeli institute the Technion have made large contributions in the field of cancer research and treatment.Technion professor Yuval Shaked, together with startup OncoHost, is responsible for the creation of a blood test that will help doctors to provide personalized treatment plans to cancer patients, and plans for clinical trials in the UK in collaboration with the country’s National Healthcare System are in the works. Read...

Read More

Latest from Twitter